Publicaciones en colaboración con investigadores/as de Complejo Hospitalario de Toledo (7)

2020

  1. Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways

    British Journal of Dermatology, Vol. 182, Núm. 1, pp. 147-155

2017

  1. Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas

    Journal of Investigative Dermatology, Vol. 137, Núm. 1, pp. 197-206

2014

  1. PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases

    PLoS ONE, Vol. 9, Núm. 11

2013

  1. Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas

    Haematologica, Vol. 98, Núm. 1, pp. 57-64

2004

  1. Posible implicación de las alteraciones moleculares de la vía de TNF en la tumorigénesis de la micosis fungoide. Descripción de un posible chip de diagnóstico molecular en micosis fungoide

    Actas Dermo-Sifiliograficas, Vol. 95, Núm. 2, pp. 86-96

2002

  1. p16INK4a is selectively silenced in the tumoral progression of mycosis fungoides

    Laboratory Investigation, Vol. 82, Núm. 2, pp. 123-132

2000

  1. p16INK4a gene alterations are frequent in lesions of mycosis fungoides

    American Journal of Pathology, Vol. 156, Núm. 5, pp. 1565-1572